CATIE, Large Study on Schizophrenia, Released

CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) is the first large scale attempt to compare five different medications used to treat people living with schizophrenia.   The study included both newer (atypical) and one older anti-psychotics.  The study was funded by the National Institute of Mental Health (NIMH) and included 1400 subjects.  The duration of the study was 18 months.

NAMI has made available several tools that can assist advocates in addressing concerns related to CATIE. 

NAMI's statement on CATIE

Ten Questions on CATIE

CATIE Raises More Questions than It Answers

The CATIE Report as Published in the New England Journal of Medicine

NIMH Perspective on Antipsychotic Reimbursement: Using Results from CATIE

 

Back to Research Page

Back to Home Page

^ page top ^